We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+30%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.29B
AUM Growth
+$370M
Cap. Flow
+$32.1M
Cap. Flow %
2.48%
Top 10 Hldgs %
19.69%
Holding
198
New
29
Increased
74
Reduced
24
Closed
25

Top Buys

Rank Stock Value
1
ARNA
Arena Pharmaceuticals Inc
ARNA
+$20.7M
2
AVTR icon
Avantor
AVTR
+$14.9M
3
TGTX icon
TG Therapeutics
TGTX
+$13.5M
4
CELL
PhenomeX Inc. Common Stock
CELL
+$11.4M
5
TXG icon
10x Genomics
TXG
+$10.3M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$20.9M
2
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$17.8M
3
GBT
Global Blood Therapeutics, Inc.
GBT
+$10.4M
4
PEN icon
Penumbra
PEN
+$10.1M
5
TWST icon
Twist Bioscience
TWST
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 48.02%
2 Technology 12.16%
3 Consumer Discretionary 8.78%
4 Industrials 6.66%
5 Financials 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JBLU icon
51
JetBlue
JBLU
$2.29B
$8.54M 0.66%
587,512
+496,444
+545% +$6.81M
C icon
52
Citigroup
C
$226B
$8.43M 0.65%
+136,767
New +$6.95M
MDLA
53
DELISTED
Medallia, Inc.
MDLA
$8.08M 0.62%
243,121
+20,484
+9% +$653K
AMZN icon
54
Amazon
AMZN
$2.96T
$8.03M 0.62%
49,320
+23,020
+88% +$3.67M
GS icon
55
Goldman Sachs
GS
$303B
$7.91M 0.61%
+30,000
New +$6.68M
JACK icon
56
Jack in the Box
JACK
$335M
$7.3M 0.56%
78,671
+13,792
+21% +$1.21M
BMRN icon
57
BioMarin Pharmaceuticals
BMRN
$12.4B
$7.15M 0.55%
81,530
-14,746
-15% -$1.17M
FRC
58
DELISTED
First Republic Bank
FRC
$7.15M 0.55%
48,646
+873
+2% +$114K
CACI icon
59
CACI
CACI
$14.2B
$7.08M 0.55%
28,412
+162
+0.6% +$37.3K
FIVN icon
60
FIVE9
FIVN
$2.54B
$6.88M 0.53%
39,460
+4,509
+13% +$686K
TWLO icon
61
Twilio
TWLO
$36.6B
$6.49M 0.5%
19,177
+191
+1% +$59.7K
CRWD icon
62
CrowdStrike
CRWD
$218B
$6.25M 0.48%
118,020
– –
VC icon
63
Visteon
VC
$2.78B
$6.2M 0.48%
49,392
+14,028
+40% +$1.48M
GTLS
64
DELISTED
Chart Industries
GTLS
$6.1M 0.47%
+51,812
New +$5M
PTVE
65
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$5.98M 0.46%
329,472
+27,576
+9% +$425K
STAY
66
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$5.85M 0.45%
395,143
+126,729
+47% +$1.64M
LRCX icon
67
Lam Research
LRCX
$390B
$5.82M 0.45%
123,210
– –
EAT icon
68
Brinker International
EAT
$9.66B
$5.6M 0.43%
98,965
+4,622
+5% +$228K
RNG icon
69
RingCentral
RNG
$5.28B
$5.47M 0.42%
14,435
+588
+4% +$183K
ZION icon
70
Zions Bancorporation
ZION
$10.3B
$5.43M 0.42%
+125,000
New +$4.62M
WAL icon
71
Western Alliance Bancorporation
WAL
$8.87B
$5.38M 0.42%
+89,668
New +$4.36M
MASS icon
72
908 Devices
MASS
$364M
$5.33M 0.41%
+93,595
New +$5.47M
SHOO icon
73
Steven Madden
SHOO
$3.55B
$5.14M 0.4%
+145,414
New +$4.13M
SEER icon
74
Seer Inc
SEER
$120M
$5M 0.39%
+88,978
New +$5.66M
BX icon
75
Blackstone
BX
$110B
$4.86M 0.38%
+75,000
New +$4.37M
1 2
3
4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Nicholas Investment Partners held 198 positions worth $1.29B, up 40% from $925M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Investment Partners's Q4 2020 filing shows 29 new, 74 increased, 24 reduced and 25 closed positions. Its largest new stake was Arena Pharmaceuticals Inc: 276,633 shares worth $21.3M. The largest sale was Immunomedics Inc, an estimated $20.9M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 48% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Nicholas Investment Partners's largest Q4 2020 buy was Arena Pharmaceuticals Inc: 276,633 shares worth $21.3M.
  • Nicholas Investment Partners added most to TG Therapeutics in Q4 2020, an estimated $13.5M increase.
  • Nicholas Investment Partners's biggest Q4 2020 reduction was Twist Bioscience, cutting an estimated $10.1M.
  • Nicholas Investment Partners fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.9M.
  • Nicholas Investment Partners's ten largest holdings make up 20% of its $1.29B portfolio in Q4 2020.
  • Nicholas Investment Partners opened 29 new positions and closed 25 in Q4 2020.
  • Nicholas Investment Partners's portfolio value rose 40% quarter-over-quarter to $1.29B.

Based on Nicholas Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.